These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23903022)

  • 1. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.
    Sigaut S; Tremey B; Ouattara A; Couturier R; Taberlet C; Grassin-Delyle S; Dreyfus JF; Schlumberger S; Fischler M
    Anesthesiology; 2014 Mar; 120(3):590-600. PubMed ID: 23903022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
    Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
    Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
    Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
    Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
    Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
    Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study.
    Faraoni D; Cacheux C; Van Aelbrouck C; Ickx BE; Barvais L; Levy JH
    Eur J Anaesthesiol; 2014 Sep; 31(9):491-8. PubMed ID: 24557022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial.
    Shi J; Ji H; Ren F; Wang G; Xu M; Xue Y; Chen M; Qi J; Li L
    JAMA Surg; 2013 Jun; 148(6):538-47. PubMed ID: 23426385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery.
    Shore-Lesserson L; Reich DL; Vela-Cantos F; Ammar T; Ergin MA
    Anesth Analg; 1996 Jul; 83(1):18-26. PubMed ID: 8659732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study].
    Peña JJ; Mateo E; Martín E; Llagunes J; Carmona P; Blasco L;
    Rev Esp Anestesiol Reanim; 2013 Mar; 60(3):142-8. PubMed ID: 22795924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of low dose tranexamic acid in primary cardiac surgery.
    Lambert W; Brisebois FJ; Wharton TJ; Carrier RC; Boyle D; Rowe BH
    Can J Anaesth; 1998 Jun; 45(6):571-4. PubMed ID: 9669014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin].
    Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A
    Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement.
    Lemay E; Guay J; Côté C; Roy A
    Can J Anaesth; 2004 Jan; 51(1):31-7. PubMed ID: 14709457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial.
    Goobie SM; Meier PM; Pereira LM; McGowan FX; Prescilla RP; Scharp LA; Rogers GF; Proctor MR; Meara JG; Soriano SG; Zurakowski D; Sethna NF
    Anesthesiology; 2011 Apr; 114(4):862-71. PubMed ID: 21364458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Wang G; Xie G; Jiang T; Wang Y; Wang W; Ji H; Liu M; Chen L; Li L
    Anesth Analg; 2012 Aug; 115(2):239-43. PubMed ID: 21737704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.